Hepatitis
Hepatitis C - Drug Pipeline Analysis and Market Forecasts to 2016
Published in Gastroenterology Week, June 14th, 2010
GlobalData's analysis suggests that the global hepatitis C market was worth $4.4 billion in 2009. It is forecast to grow at a Compound Annual Growth Rate (CAGR) of 9.8% for the next seven years to reach $8.5 billion by 2016. The high projected growth rate is primarily attributable to a strong pipeline. The increase in the prevalence of the disease and the availability of new first-in-class therapies with better safety and efficacy profiles are expected to drive the growth of the hepatitis C market.
GlobalData analyzed the current competitive landscape for hepatitis C drugs and found that the competition is weak. There are six commonly used approved products for the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- Ulcerative Colitis
Data on ulcerative colitis discussed by researchers at Federal University of Sao Paulo, Division of Pediatric Gastroenterology - Marketing Services
Prompt gallbladder removal in elderly associated with increased survival, lower costs - Fatty Liver Disease
Study data from Tongji University update knowledge of fatty liver disease - Inflammatory Bowel Disease
New inflammatory bowel disease study findings have been published by scientists at University of Pennsylvania - Clinical Nursing
Recent findings from Orebro University, Family Medicine Research Center highlight research in clinical nursing - Ulcerative Colitis
New ulcerative colitis research has been reported by scientists at Kyoto University, Medical Department - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
